ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 105023 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 105023; 2) Community: the network communities that were significantly associated with the response to NSC 105023; 3) Molecule: the relationships between components within communities and NSC 105023; 4) MDR: the compounds that were significantly associated with the NSC 105023.

NSC Compound Enrichment Correlation
NSC 174218 Phenol, 2,2'-[1,2-ethanediylbis(nitrilomethylidyne)]bis-, compd. with dichlorodipropylstannane (1:1) 0.0247898374452139 -0.049226966
NSC 240529 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- 0.0247898374452139 0.53850376
NSC 28002 Naphtho[2,1-b]quinolizinium, 7-methyl-, chloride 0.0247898374452139 -0.081393465
NSC 284751 Adenosine, 8-chloro-, cyclic 3',5'-(hydrogen phosphate) 0.0247898374452139 0.47972651
NSC 33568 1-Propanone, 1,2-diphenyl-3-(1-piperidinyl)- (9CI) 0.0247898374452139 0.34582331
NSC 345647 CHAETOCHROMIN 0.0247898374452139 0.30213958
NSC 405158 2,5-Cyclohexadiene-.delta.1,.alpha.-acetonitrile, .alpha.-(p-chlorophenyl)-4-oxo-, oxime 0.0247898374452139 0.43331572
NSC 606985 Camptothecin Derivative 0.0247898374452139 0.55938317
NSC 613327 Gemcitabine Y 0.0247898374452139 0.49532207
NSC 619688 Null 0.0247898374452139 0.37191884
Total:121  Current:74    [First] [Prev] [Next] [Last]